E0 ConsensusPreliminaryPEM ?Review-NarrativePeer-reviewedMachine draft
[Long COVID - neurological or somatoform disease?].
Tényi, Dalma, Tényi, Tamás, Janszky, József · Ideggyogyaszati szemle · 2024 · DOI
Quick Summary
This study reviews research on long COVID to understand what causes its main symptoms like extreme fatigue, pain, and brain fog. Doctors are still debating whether long COVID is primarily a brain/nerve disease, a whole-body illness affecting multiple systems, or a condition where the brain becomes overly sensitive to signals. The researchers found that long COVID shares many similarities with ME/CFS and other hard-to-diagnose conditions, but no single test currently exists to confirm long COVID diagnosis.
Why It Matters
This review is crucial because it clarifies the current state of long COVID research and its striking similarities to ME/CFS—a condition that has long struggled for recognition and understanding. By synthesizing competing theories, this work helps patients and clinicians understand why long COVID remains diagnostically challenging and emphasizes the urgent need for biomarker discovery. Clear understanding of disease mechanisms is essential for developing targeted, effective treatments for both conditions.
Observed Findings
- Three main theoretical frameworks for long COVID pathomechanism are documented in the literature: neurological, systemic, and psychoneuroimmunological models.
- Long COVID shares significant clinical overlap with ME/CFS, Gulf War syndrome, chronic Lyme disease, and somatic symptom disorder.
- No reproducible, disease-specific biomarker has been identified for long COVID despite intensive research.
- The most common long COVID symptoms are fatigue, diffuse pain, post-exertional malaise, and cognitive impairment (brain fog).
- Long COVID is defined as persistent symptoms lasting at least 2 months following confirmed or suspected SARS-CoV-2 infection.
Inferred Conclusions
- Long COVID pathomechanism remains unknown, likely involving complex interactions between direct viral effects, immune dysregulation, and central sensitization.
- The nonspecific symptom profile and diagnostic uncertainty in long COVID parallels longstanding challenges in ME/CFS diagnosis and classification.
- Elucidating long COVID's true etiology is essential for developing appropriate, evidence-based therapeutic interventions.
- The absence of disease-specific biomarkers suggests that current diagnostic frameworks may be inadequate and that novel research approaches are needed.
Remaining Questions
What This Study Does Not Prove
This review does not prove which pathomechanism is correct—these remain competing theories without definitive evidence favoring one over the others. The study cannot identify disease-specific biomarkers itself; it only confirms that none have been reliably validated to date. The overlaps identified with ME/CFS suggest common mechanisms but do not establish whether long COVID and ME/CFS are identical conditions or distinct entities with shared features.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionPainFatigue
Biomarker:Cytokines
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- DOI
- 10.18071/isz.77.0397
- PMID
- 39635815
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026